Introduction
One of the most disabling aspects of epilepsy is the unpredictability of epileptic seizures. During a seizure a person is generally unaware and unable to call for help. Many people with epilepsy or their carers keep seizure diaries, but there is a difference between recording and detecting seizures and diaries have been shown to be rather unreliable [1] . However, the use of a detecting devise linked to an electronic diary could be of practical benefit for the seizure management. The aim of this study is to systemically review the quality of evidence supporting seizure detection devices.
Theory
Seizure detection studies have focused on detecting physiological changes that occur before and during a seizure. Such as increased cerebral oxygen levels, alteration of movements, heart rate changes, electrical activity in muscles and changes in galvanic skin resistance. In addition there are also studies of dogs that appear to detect seizures. This review paper describes studies that have practical implications for clinical practice.
Purpose:
The study aims to review systematically the quality of evidence supporting seizure detection devices. The unpredictable nature of seizures is distressing and disabling for sufferers and carers. If a seizure can be reliably detected then the patient or carer could be alerted. It could help prevent injury and death. Methods: A literature search was completed. Forty three of 120 studies found using relevant search terms were suitable for systematic review which was done applying pre-agreed criteria using PRISMA guidelines. The papers identified and reviewed were those that could have potential for everyday use of patients in a domestic setting. Studies involving long term use of scalp electrodes to record EEG were excluded on the grounds of unacceptable restriction of daily activities. Results: Most of the devices focused on changes in movement and/or physiological signs and were dependent on an algorithm to determine cut off points. No device was able to detect all seizures and there was an issue with both false positives and missed seizures. Many of the studies involved relatively small numbers of cases or report on only a few seizures. Reports of seizure alert dogs are also considered. Conclusion: Seizure detection devices are at a relatively early stage of development and as yet there are no large scale studies or studies that compare the effectiveness of one device against others. The issue of false positive detection rates is important as they are disruptive for both the patient and the carer. Nevertheless, the development of seizure detection devices offers great potential in the management of epilepsy ß 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Material and methods
A literature search was carried out using the search terms: epilepsy, epileptic, seizure, alarm, monitor, device, sensor, safety, protection, mobile/smart phone, pillow, mat, mattress, physiologic, accelerometer, home, community, moisture, technology. The following databases -Medline, Cinal and Embase were used for this review. In addition 9 organisations were contacted for details of any relevant studies. Only one organisation provided a further study that was not included in the original literature search. Altogether, 120 studies were examined. 68 of the papers were excluded from the review because they involved the use of scalp electrodes to continuously record EEG data. Not only was this very intrusive and impractical for everyday life but the majority of patients would refuse to wear on a long term basis [2] . Similarly 4 studies were excluded because they involved implanted devices and were not relevant for most people with epilepsy.
The remaining 48 studies were then assessed using the guidance of the PRISMA [3] on the following 5 criteria for inclusion in this review:
1. use of control cases 2. confirmed diagnosis 3. 10 or more cases 4. identification of false positives 5. quality of life mentioned
The criteria was decided and confirmed by an expert focus group. None of the studies met all 5 of the inclusion criteria, but 19 met at least 3 and form the basis of this review. A further 16 studies were included because they added interesting information even though they failed to meet the inclusion standard. They are marked in the text with an asterisk.
Results

Movement sensors
A pressure sensor mat is placed under the sheet or mattress to detect abnormal movement or absence of movement. They can usually be adjusted to allow for the patient's weight and for normal sleep movements. Nevertheless they were very variable in their success in detecting seizures. The most successful device (n = 79) detected 89% of tonic clonic seizures [4] . But another study detected only 30% of nocturnal tonic clonic seizures (n = 45) [5] . In a study comparing two seizure movement alarms corroborated by vEEG, one alarm didn't detect any nocturnal seizures whilst the other detected 66% (n = 15) [6] .
The specificity of movement monitors is questionable. One study (n = 64) recorded 269 false positive results [7] . While another study noted numerous false alarms and 28 patients had to be excluded from the study due to faulty sensors, false positives and difficulties differentiating seizures from movements associated with getting out of bed [4] .
In spite of these problems, this type of sensor is currently the first choice for many people, perhaps because of its simplicity [8] . A study carried out by the Maxwell Muir Foundation found that 90% of parents were satisfied with bed sensors for their children and believed that most seizures were detected in spite of false alarms (Panwar, unpublished) [40] .
Accelerometers
An accelerometer is a device that measures both motion and changes in velocity in either 2 or 3 dimensions. For example, smart phones have a 3-way axis which detects when they are tilted, rotated, or moved. A study [9] pointed out that vEEG was too uncomfortable for long term use and that wearing small accelerometers on the limbs was user friendly and able to provide long term monitoring of tonic clonic seizures. A sensitivity of 95% was observed in a study (n = 7) using four accelerometers, but with noticeable inter-patient difference [10] . This was supported by the finding of another study (n = 73) which showed a sensitivity of 91% using a single wrist worn unit [11] The specificity and sensitivity of an accelerometer is dependent on the associated algorithm to analyse the rate, amplitude, intensity, duration and rhythm of the motor component of the seizure and it has been suggested that a minimum of two accelerometers are needed to reliably detect nocturnal convulsive seizures [12] . However it was reported on a commercially available smart watch that could be worn on any limb and had the advantage of communicating with a smartphone via Bluetooth and the ability to set the sensitivity [13] . 15 patients were monitored with vEEG and all generalised tonic clonic seizures (GTCS) were identified. A similar set up with a single wrist attached device and vEEG monitoring detected 87% of GCTS but with multiple false positives [14] Most studies report on small numbers of cases with variable specificity (correctly identifying genuine seizures). Ceulemans et al. [15] noted a specificity of 84% (n = 3) with clearly marked motor manifestations in their nocturnal seizures, but Van De Vel et al. [16] noted a specificity of only 58% for nocturnal hyper motor seizures in seven patients. In a larger study of 49 patients Van De Vel et al. [17] found that no parameter setting was 100% sensitive or specific for all patients. They observed a specificity between 35% and 100% in detecting seizures.
False positive rates also vary. Beniczky et al. [11] observed a very low false positive rate of once every 5 days (n = 73) while Sabesan et al. [18] found a higher mean false positive of 2.1 per night in a multi-modal device incorporating both an accelerometer and ECG. The speed of seizure detection is also an important factor and Kramer et al. [19] found that 91% of seizures were detected within a median period of 17 s, and all events were identified within 30 s.
Devices that measure physiological change
Seizure onset can be detected by changes in the autonomic nervous system [20] . A pilot study by Poh et al. [21] observed that epileptic seizures induce a decrease in skin resistance due to increased sweating. A further study based on galvanic skin resistance and accelerometers in seven patients found that the device detected 94% of the generalised tonic clonic seizures (GTCS) with a false positive rate of 0.74 per 24 h. [22] Seizure detection using heart rate has been observed to correlate well with electrocorticoencephalography (ECoG) However, this varied from person to person and its clinical relevance is unproven [23] Physiological signals of movement and heart rate were assessed for home seizure detection in 92 patients, but a high sensitivity was found to be necessary for algorithms to be implementable [24] . Kroner et al. [25] measured heart rate, respiration and electromyography (N = 7) and concluded that cardiac parameters alone were able to identify 100% of GTCS and 94% of myoclonic seizures. Other physiological approaches for detecting seizures have been investigated such as the use of an apnoea device worn over the trachea which identified 88% of sleep apnoea events in 10 subjects and a specificity of 99% (Rodruigez-Villegas et al., 2014) [39] .
Electromyography (EMG)
Electromyography measures changes in the electrical activity in muscles. There is no current EMG device available for home use but the potential for this device is good with high levels of specificity. In a study of 29 subjects, corroborated by vEEG, the EMG algorithm being developed detected all GTCS within 30 s with no false positives [26] . In a larger study of 118 people a similar high level of specificity was observed. The Sensitivity was comparable to United States Federal Drug Agency cleared, automated EEG seizure detection algorithms [27] .
Video and infrared devices
Chan et al. [28] concluded that video monitoring for seizure detection is feasible but needs further development (n = 5). A study of video surveillance by Cuppens et al. [29] specifically looked at the detection of nocturnal myoclonic jerks in 8 subjects and found a sensitivity of over 75% but this was uncorroborated by EEG. The use of infrared movement monitors has been reported by Shankar et al. [30] Shankar et al. [31] . They found that movements correlate well with carer reports of seizures (n = 5). A study that measured changes in haemoglobin oxygenation using infrared spectroscopy was found to be unsuitable for seizure detection [32] .
Seizure alert dogs (SAD)
The ability of some dogs to detect seizures minutes or hours before a seizure has been reported. A case study of an untrained pet dog reported by Lyons et al. [33] observed that the dog was able to detect seizures with 100% accuracy and no false positives. This was corroborated by EEG. Another study found 9 dogs that responded to a seizure but only 3 of these alerted to seizure onset [34] . Whether the dogs can anticipate true epileptic seizures has been questioned, since they have been observed to alert to both epileptic and non-epileptic seizures, but the same study found that patients with a SAD experience a reduction in the number of seizures. [35] .
Discussion
Given the importance of seizure detection there is a lack of large scale studies and few that compare the effectiveness of available devices. There are a number of innovative technologies that have been considered but the findings are rarely corroborated by vEEG. Also the numbers in some of the larger studies can be deceptive. [7] reported on 64 patients, but with only 8 GTCS recorded.
Care must be taken in the interpretation of results. For example, studies are often carried out by the team that developed the device or are sponsored by the manufacturer and the results are often favourable raising the question of possible bias. We noted that the studies are mostly confined to just a few centres with some reports using the same clinical sample in several papers. In addition, the device manufacturer's web sites may give misleading information supporting their product. For example, one website advertised a seizure alert device and cited numerous studies supporting their device but only one paper actually referred to epilepsy. Of great concern is that social media marketing of some commercial devices specify that the device is designed to prevent SUDEP without any supporting evidence.
False positives and missed seizures are an important issue, but by their nature are difficult to accurately record and some studies were not corroborated by EEG monitoring. Seizure reporting by carers may also be subjective and inaccurate which adds to the uncertainty about the efficiency of the devices. Algorithms and device design also differ widely so it is difficult to say with any certainty how effective a particular device might be for an individual patient as there was notable inter-patient difference in detection rates within some studies [36] .
Although some of the studies state that the device improved quality of life, it was unclear how this was measured and frequent disturbance by an alarm at night may have a detrimental impact on patients and carers. It was interesting to note that there are no studies of a simple baby listening device or CCTV which is both cheap and readily available. These devices might offer some reassurance to parents and carers but are not yet tested for sensitivity or specificity.
Future trends
As technology advances, particularly the personal ownership of powerful devices such as smartphones and smartwatches, innovations in the self-monitoring of seizures and related variables are on the increase. For example, Embrace, a smart watch based App, has recently been developed to support the self-monitoring of stress and activity levels with additional claims that it can capture convulsive seizures and alert others via its link to an smartphone (www.empatica.com/ embrace-watch-epilepsy-monitor). However any studies to establish this are yet to be published.
Another, newer example of using smart-watches for epilepsy is EpiWatch, an app designed for use on an Apple Watch with its paired iPhone (http://www.hopkinsmedicine.org/epiwatch#. Vkel7dLhBdh). EpiWatch is using Apple's ResearchKit framework to develop a multi-modal seizure detector based on seizurerelated movements, heart rate changes, and patient interactions with the app. While participating in research, patients are rewarded with helpful and engaging tools to track their condition. Again research is needed to establish its advantages and disadvantages.
Although this article excluded implantable devices, livaNova/ Cyberonics have recently developed a Vagal Nerve Stimulator which can be linked with an ECG to identify ictal tachycardia and provide automated therapy by stimulating the vagal nerve at a predetermined heart rate. [37] Increased awareness of risk, including SUDEP, amongst people with epilepsy, carers and organisations is also influencing future trends on safety devices. A statement of research need on epilepsy deaths from UK research teams in 2014 flagged up detection devices that may prevent SUDEP as an important area for funding (https://www.sudep.org/statement-research-need).
Ultimately, the best protection against injury or fatality due to epilepsy is early recognition of risk and appropriate clinical intervention. EpSMon (Epilepsy Self-Monitor) www.sudep.org// epilepsy-self-monitor, a smartphone based App [38] , provides a translation of the clinicians' SUDEP and Seizure Safety checklist https://www.sudep.org/checklist ( [30] , [31] ) into a self-administered questionnaire, which monitors changes in risk over time, provides appropriate education and recommends clinical contact when appropriate. It works on the principle that worsening of seizures are a function of cumulative increase in seizure, biological, social and psychological factors.
Conclusion
The body of work in this literature review represents the best information available at this time. It is not surprising that people with epilepsy and their carers recognise the potential benefit of seizure detection devices. Appropriate communication between doctors and patients about new technologies needs to be well supported. Professionals need to be able to assess the evidence and offer realistic advice to people with epilepsy and their carers to reduce their exposure to risk. For this reason, it is important that that the available evidence on the risks and benefits of this technology is set out clearly for open access preferably via mainstream peer reviewed scientific journals.
But ultimately the choice of a device is down to seizure type, personal circumstances, lifestyle and acceptance of risk. As far as we are aware, none of the devices is registered as a medical device and although seizure alarms may offer some peace of mind, clinicians need to be clear about what the device is detecting and that seizures may be missed or falsely reported.
We conclude that it is important to exercise caution when recommending or providing a commercially available device that claims to detect seizures and to bear in mind that there is no evidence that any of them could prevent SUDEP. Care providers should also be careful when requesting a seizure alert device and advice should always be sought beforehand from an epilepsy specialist and the risks discussed and understood.
The review does not look into other related factors such as problems in practically setting up devices, recognition and addressing any malfunction and the issue of servicing the device.
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ECG data and accelerometer data evaluated separately a retrospective study using data from 581 hrs of ECG data collected from epilepsy monitoring units. Overall performance was reasonable.
Greater than 80% mean sensitivity. a mean sensitivity of 80% and a mean false positive of 2 per night.
Seizures detected by the cardiac algorithm were largely complex focal seizures with or without secondary generalisation.
The accelerometer detected 97% of seizures with movement. 
